+987.9%
MRNA vs FFIV
+33.5%
+954.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FFIV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -0.4% | +13.5% | +13.1% |
| 7D | +20.6% | -9.8% | +30.4% | +19.0% |
| 30D | +27.1% | -28.1% | +55.2% | +21.8% |
| 3M | +353.4% | -20.0% | +373.4% | +361.3% |
| 6M | +446.3% | -0.1% | +446.3% | +425.2% |
| YTD | +776.2% | +29.2% | +747.0% | +665.8% |
| 1Y | +987.9% | +36.6% | +951.3% | +806.6% |
| All | +987.9% | +33.5% | +954.4% | +806.6% |
Cumulative growth
Daily Returns
Daily percentage return beside FFIV.
Daily Out/Under-Performance
Portfolio return minus FFIV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FFIV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FFIV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling